EC
CGON icon

Eleva Capital’s CG Oncology CGON Stock Holding History

Eleva Capital’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-8,289
Closed -$561K – 30
2026
Q2 		$561K Hold
8,289
– – 0.16% 15
2026
Q1 		$561K Buy
+8,289
New +$470K 0.16% 15

Other funds holding CGON

VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM

Eleva Capital's CGON Position: Q3 2026 in Review

Eleva Capital sold out of CG Oncology (CGON) in Q3 2026, closing a stake of 8,289 shares — an estimated $561K sold.

Eleva Capital first reported a position in CGON in Q1 2026 and held it in 2 quarters. The position peaked at $561K in Q2 2026. 3 funds tracked by Wall St. Rank hold CGON as of Q3 2026.

  • Eleva Capital reported no remaining CG Oncology position as of Q3 2026 after selling out during the quarter.
  • Eleva Capital sold 8,289 CG Oncology shares in Q3 2026, an estimated $561K.
  • Eleva Capital first reported a position in CG Oncology in Q1 2026 and held it in 2 quarters.
  • Eleva Capital's CG Oncology position peaked at $561K in Q2 2026.
  • 3 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.

Based on Eleva Capital's 13F filing for Q3 2026, filed 6 Oct 2026.